The latest data point for NKE's operating expenses in Q3'26 shows R&D expenses at $0, with SG&A expenses at $3.98B, resulting in total operating expenses of $3.98B. This reflects a stable but slightly declining position in the most recent quarter, consistent with the unit of USD for large-currency formatting. Over the period from Q4'23 to Q3'26, SG&A expenses have exhibited a mild downward trend, decreasing from $4.37B to $3.98B, with minor fluctuations including a low of $3.89B in Q3'25 and a rebound to $4.15B in Q4'25. R&D expenses remained at $0 throughout, indicating no allocation in this category and underscoring SG&A as the dominant component of operating expenses in this stacked bar chart. Overall, the data suggests controlled cost management amid potential economic pressures, with total expenses averaging around $4.1B quarterly.